Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells.
DC maturation
T cell activation
antigen presentation
dendritic cells (DCs)
immune evasion
immunity
inflammation
recurrent infection
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2019
2019
Historique:
received:
14
12
2018
accepted:
26
03
2019
entrez:
7
5
2019
pubmed:
7
5
2019
medline:
22
7
2020
Statut:
epublish
Résumé
The human respiratory syncytial virus (hRSV) is the leading cause of pneumonia in infants and produces a significant burden in the elderly. It can also infect and produce disease in otherwise healthy adults and recurrently infect those previously exposed to the virus. Importantly, recurrent infections are not necessarily a consequence of antigenic variability, as described for other respiratory viruses, but most likely due to the capacity of this virus to interfere with the host's immune response and the establishment of a protective and long-lasting immunity. Although some genes encoded by hRSV are known to have a direct participation in immune evasion, it seems that repeated infection is mainly given by its capacity to modulate immune components in such a way to promote non-optimal antiviral responses in the host. Importantly, hRSV is known to interfere with dendritic cell (DC) function, which are key cells involved in establishing and regulating protective virus-specific immunity. Notably, hRSV infects DCs, alters their maturation, migration to lymph nodes and their capacity to activate virus-specific T cells, which likely impacts the host antiviral response against this virus. Here, we review and discuss the most important and recent findings related to DC modulation by hRSV, which might be at the basis of recurrent infections in previously infected individuals and hRSV-induced disease. A focus on the interaction between DCs and hRSV will likely contribute to the development of effective prophylactic and antiviral strategies against this virus.
Identifiants
pubmed: 31057543
doi: 10.3389/fimmu.2019.00810
pmc: PMC6478035
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
810Références
J Virol. 1999 Aug;73(8):6610-7
pubmed: 10400758
Annu Rev Immunol. 2000;18:767-811
pubmed: 10837075
Virology. 2000 Jun 5;271(2):264-75
pubmed: 10860881
Biochem Biophys Res Commun. 2001 Jan 12;280(1):188-95
pubmed: 11162498
Rev Med Virol. 2001 Mar-Apr;11(2):103-16
pubmed: 11262529
J Virol. 2001 Aug;75(15):6825-34
pubmed: 11435561
J Virol. 2002 Feb;76(3):1163-70
pubmed: 11773392
Nat Immunol. 2002 Jul;3(7):673-80
pubmed: 12055625
J Virol. 2003 Apr;77(8):4950-9
pubmed: 12663800
Immunology. 2003 May;109(1):49-57
pubmed: 12709017
J Pediatr. 2003 Nov;143(5 Suppl):S112-7
pubmed: 14615709
J Allergy Clin Immunol. 2004 Jan;113(1):127-33
pubmed: 14713917
J Immunol. 2004 Sep 15;173(6):4058-65
pubmed: 15356155
J Infect Dis. 2005 Apr 1;191(7):1105-15
pubmed: 15747246
J Virol. 2005 May;79(9):5353-62
pubmed: 15827150
J Virol. 2005 Jul;79(13):7990-8003
pubmed: 15956545
Clin Infect Dis. 2005 Aug 1;41(3):311-7
pubmed: 16007526
J Immunol. 2005 Nov 1;175(9):5904-11
pubmed: 16237083
Am J Respir Cell Mol Biol. 2006 Mar;34(3):320-9
pubmed: 16284360
Clin Exp Immunol. 2006 Mar;143(3):513-22
pubmed: 16487251
J Virol. 2006 May;80(10):5032-40
pubmed: 16641294
J Exp Med. 2006 May 15;203(5):1153-9
pubmed: 16682497
Eur J Immunol. 2006 Jun;36(6):1434-42
pubmed: 16708402
J Immunol. 2006 Aug 15;177(4):2536-42
pubmed: 16888015
Curr Top Microbiol Immunol. 2006;311:17-58
pubmed: 17048704
J Immunol. 2006 Nov 1;177(9):6207-14
pubmed: 17056550
J Immunol. 2006 Nov 1;177(9):6263-70
pubmed: 17056556
Infect Immun. 2006 Nov;74(11):6438-48
pubmed: 17057096
J Biochem. 2007 Feb;141(2):137-45
pubmed: 17190786
J Virol. 2007 Apr;81(7):3428-36
pubmed: 17251292
Cytokine Growth Factor Rev. 2007 Feb-Apr;18(1-2):19-31
pubmed: 17344089
Immunology. 2007 Sep;122(1):65-72
pubmed: 17472722
Clin Exp Immunol. 2007 Nov;150(2):263-73
pubmed: 17892510
Immunology. 2008 Aug;124(4):522-33
pubmed: 18266715
PLoS One. 2008 Mar 05;3(3):e1720
pubmed: 18320041
Protein Sci. 2008 May;17(5):813-20
pubmed: 18369195
J Virol. 2008 Sep;82(17):8780-96
pubmed: 18562519
Int Immunopharmacol. 2008 Oct;8(10):1320-9
pubmed: 18687294
Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14999-5004
pubmed: 18818306
Virol J. 2008 Oct 13;5:116
pubmed: 18851747
Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20822-7
pubmed: 19075247
Virology. 2009 Mar 1;385(1):169-82
pubmed: 19128816
J Immunol. 2009 Mar 1;182(5):3072-83
pubmed: 19234204
J Virol. 2009 Jul;83(14):7235-43
pubmed: 19420085
Eur J Immunol. 2010 Apr;40(4):1042-52
pubmed: 20101616
J Infect Dis. 1991 Apr;163(4):693-8
pubmed: 2010624
Am J Respir Cell Mol Biol. 2011 May;44(5):655-64
pubmed: 20595462
Immunol Cell Biol. 2011 Feb;89(2):231-8
pubmed: 20603637
J Virol. 2010 Dec;84(24):12895-902
pubmed: 20926560
Virus Res. 2011 Mar;156(1-2):127-33
pubmed: 21255624
PLoS One. 2011 Jan 28;6(1):e16458
pubmed: 21297989
Immunotherapy. 2011 Apr;3(4 Suppl):6-11
pubmed: 21524159
PLoS Pathog. 2011 Apr;7(4):e1001336
pubmed: 21533073
PLoS Pathog. 2011 Jun;7(6):e1002105
pubmed: 21731495
Nat Med. 2011 Aug 14;17(9):1132-5
pubmed: 21841784
Semin Respir Crit Care Med. 2011 Aug;32(4):423-32
pubmed: 21858747
Int Arch Allergy Immunol. 2012;157(1):21-30
pubmed: 21894025
J Immunol. 2011 Oct 15;187(8):3953-61
pubmed: 21911604
J Virol. 2012 Feb;86(3):1339-47
pubmed: 22090124
J Immunol. 2012 Feb 15;188(4):1647-55
pubmed: 22266281
Rev Med Virol. 2012 Jul;22(4):230-44
pubmed: 22290692
Curr Mol Med. 2013 Aug;13(7):1122-39
pubmed: 23157678
Eur J Immunol. 2013 Feb;43(2):488-98
pubmed: 23169007
Microbes Infect. 2013 Mar;15(3):230-42
pubmed: 23246463
MBio. 2012 Dec 18;3(6):null
pubmed: 23249809
J Leukoc Biol. 2013 Jul;94(1):5-15
pubmed: 23293372
Annu Rev Immunol. 2013;31:563-604
pubmed: 23516985
J Virol. 2013 Jun;87(12):7075-92
pubmed: 23596302
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9112-7
pubmed: 23650398
J Gen Virol. 2013 Aug;94(Pt 8):1734-8
pubmed: 23677789
Respir Res. 2013 Jul 05;14:71
pubmed: 23829893
J Immunol. 2013 Sep 1;191(5):2526-37
pubmed: 23894198
J Clin Invest. 2013 Sep;123(9):3967-82
pubmed: 23945235
Curr Top Microbiol Immunol. 2013;372:83-104
pubmed: 24362685
Influenza Other Respir Viruses. 2014 Jul;8(4):469-73
pubmed: 24528606
PLoS Pathog. 2014 Feb 13;10(2):e1003934
pubmed: 24550729
PLoS One. 2014 Mar 20;9(3):e91855
pubmed: 24651119
Immunol Res. 2014 Aug;59(1-3):109-17
pubmed: 24838148
Inflammation. 2014 Dec;37(6):1984-2005
pubmed: 24906563
J Virol. 2014 Aug;88(16):9350-60
pubmed: 24920801
Immune Netw. 2014 Jun;14(3):128-37
pubmed: 24999309
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):E3214-23
pubmed: 25056968
Rev Med Virol. 2014 Nov;24(6):407-19
pubmed: 25316031
Eur J Immunol. 2015 Jan;45(1):32-9
pubmed: 25403892
Mucosal Immunol. 2015 Jul;8(4):746-59
pubmed: 25465101
Mol Cell Proteomics. 2015 Mar;14(3):532-43
pubmed: 25556234
J Virol. 2015 Apr;89(7):3484-96
pubmed: 25568210
PLoS One. 2015 Mar 16;10(3):e0121527
pubmed: 25775126
PLoS Pathog. 2015 Jun 17;11(6):e1004978
pubmed: 26083387
J Immunol. 2015 Aug 15;195(4):1637-46
pubmed: 26157176
J Immunol Res. 2015;2015:743169
pubmed: 26229971
Immunology. 2016 Jan;147(1):55-72
pubmed: 26451966
Virus Res. 2016 Jan 4;211:117-25
pubmed: 26474524
Int Immunopharmacol. 2015 Dec;29(2):408-415
pubmed: 26603638
Clin Vaccine Immunol. 2015 Dec 16;23(3):189-95
pubmed: 26677198
Immunol Rev. 2016 Jul;272(1):97-108
pubmed: 27319345
Semin Respir Crit Care Med. 2016 Aug;37(4):522-37
pubmed: 27486734
J Mol Model. 2016 Dec;22(12):286
pubmed: 27817112
Nat Rev Immunol. 2017 Jan;17(1):30-48
pubmed: 27890914
J Immunol. 2017 Jan 1;198(1):394-403
pubmed: 27895172
Front Cell Infect Microbiol. 2016 Dec 12;6:174
pubmed: 28018859
J Biol Chem. 2017 Feb 10;292(6):2120-2131
pubmed: 28031463
Vaccine. 2017 Feb 1;35(5):757-766
pubmed: 28065474
J Virol. 2017 Feb 28;91(6):
pubmed: 28077651
Virology. 2017 Apr;504:63-72
pubmed: 28157546
Immunity. 2017 Feb 21;46(2):301-314
pubmed: 28228284
Int Immunopharmacol. 2017 May;46:62-69
pubmed: 28259002
J Immunol. 2017 Mar 15;198(6):2223-2231
pubmed: 28264998
Mucosal Immunol. 2018 Jan;11(1):186-198
pubmed: 28378805
J Leukoc Biol. 2017 Jul;102(1):153-161
pubmed: 28389622
Hum Vaccin Immunother. 2017 Sep 2;13(9):2092-2097
pubmed: 28598702
Viral Immunol. 2017 Jul/Aug;30(6):421-430
pubmed: 28650258
Infect Dis Ther. 2017 Sep;6(3):383-411
pubmed: 28653300
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
Commun Integr Biol. 2017 May 8;10(3):e1319025
pubmed: 28702128
Viruses. 2017 Aug 03;9(8):
pubmed: 28771197
J Clin Virol. 2017 Oct;95:26-35
pubmed: 28837859
PLoS One. 2017 Oct 13;12(10):e0184629
pubmed: 29028839
Front Immunol. 2017 Nov 10;8:1523
pubmed: 29176979
Immunology. 2018 May;154(1):122-131
pubmed: 29178427
Semin Cell Dev Biol. 2018 Dec;84:11-21
pubmed: 29246859
PLoS Pathog. 2017 Dec 27;13(12):e1006803
pubmed: 29281742
Rev Med Virol. 2018 Mar;28(2):
pubmed: 29377415
Immunol Lett. 2018 Apr;196:91-102
pubmed: 29427742
Sci Immunol. 2018 Mar 9;3(21):
pubmed: 29523582
Med Mal Infect. 2018 Sep;48(6):377-382
pubmed: 29548714
Lancet Infect Dis. 2018 Oct;18(10):e295-e311
pubmed: 29914800
Front Immunol. 2018 Jun 04;9:1249
pubmed: 29915592
BMC Res Notes. 2018 Jul 3;11(1):432
pubmed: 29970194
PLoS One. 2018 Sep 10;13(9):e0203788
pubmed: 30199549
J Biol Chem. 2018 Oct 26;293(43):16761-16777
pubmed: 30206124
Viruses. 2018 Sep 30;10(10):
pubmed: 30274351
MBio. 2018 Nov 13;9(6):
pubmed: 30425144
Clin Infect Dis. 2018 Nov 19;:null
pubmed: 30452608
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13961-6
pubmed: 9391135
Nature. 1998 Mar 19;392(6673):245-52
pubmed: 9521319